CD8A and neoplasm: Studies have reported that CD4+T cells inhibit tumor progression in three ways, including secreting inflammatory factors to promote the cytotoxicity of NK cells, myeloid cells and CD8+T cells; affecting the function of B cells to assist the production of specific antibodies; and directly recognizing and killing tumor cells through MHCII7.